Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai FukumuraDepartment of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAJonas KloepperDepartment of Oncology, Centre Hospitalier Universitaire Vaudois, University of Lausanne (CHUV-UNIL), Lausanne, Vaud, SwitzerlandZohreh AmoozgarEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USADan G. DudaEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USARakesh K. JainDepartment of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
2018en
Ochiq kirishYashil
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba